HBS Life Science Investing: Risk Capital to Success Story
As a life science entrepreneur, raising capital is an exciting, challenging and a somewhat daunting experience. In the Philadelphia metro region, it has been more difficult since the 2008-2009 economic recession. Our Life Sciences community has lost businesses, jobs and investment capital to other regions across the USA. Upon the exit of these investment dollars, local entrepreneurs have found it tough to obtain seed money, and more problematic to acquire funding that could lead towards eventual commercialization and positive cash flow.
With this challenge in mind, members of the Life Sciences Collaborative have designed our 4th annual conference around this conversation. Our robust panels include leaders from life science investment management, regional incubators and biopharma firms. This program is focused on changing the game and reversing the trend of reduced access to investment capital in this region. Our panels of industry leaders will offer their guidance and real world experiences to help build your entrepreneurial skill set towards increased success within the Philadelphia metro area.
Dr. Stephen Tang - President & CEO at University City Science
Adam Dakin - CEO of PhotoSonix Medical and Co-Founder and Partner of PLEXUS Innovation
To accomplish our goal of our annual event to address two key areas in the complex issue of obtaining funding, we have assembled powerhouse Panelists:
Building a Successful Pitch for Investor Discussions
Moderator Dean Miller, President & CEO of PACT
J. David Owens, CEO of BiologicsMD
Michael Wells, Managing Partner of Princeton Biopharma Capital
Osagie Imasogie, Chairman of Iroko Pharma and Churchill Pharma
Pete Buzy, CEO of Paragon Biosciences (Portfolio Company of NewSpring Capital)
Seed Money and Beyond: Improving the Flow of Investment Funds to our Region
Moderator Matt Cabrey (Exec. Dir. of Select Greater Philadelphia) as Panel’s Moderator
Mark Tepper who has been a seasoned entrepreneur and is the Founder, President and Chief Scientific Officer of the Corbus Pharmaceuticals (NASDAQ: CRBP)
Michael Poisel, Director or the Penn Center for Innovation Ventures
Jane Hollingsworth, Managing Partner at Militia Hill Ventures
Heather Steinman, PhD, Executive Director of Technology Transfer at Wistar Institute
Please join us for an exciting and informative day as we learn from powerhouse speakers of how to attract the money needed to fund your dreams so that one day, they can become a reality.
Continental Breakfast, Lunch, and Free Parking are included.
Life Science Investing: Risk Capital to Success Story
Tuesday, March 7th, 2017 from 8:00am-2:00pm
University of the Sciences | McNeil Science and Technology Center
Astra Zeneca Auditorium (STC Room 145)
723 South 45th Street & Woodland Avenue
Philadelphia, PA 19104